These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19919101)

  • 21. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
    Chen CC; Herzberg O
    Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate.
    Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR
    Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.
    Nukaga M; Bethel CR; Thomson JM; Hujer AM; Distler A; Anderson VE; Knox JR; Bonomo RA
    J Am Chem Soc; 2008 Sep; 130(38):12656-62. PubMed ID: 18761444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
    Drawz SM; Babic M; Bethel CR; Taracila M; Distler AM; Ori C; Caselli E; Prati F; Bonomo RA
    Biochemistry; 2010 Jan; 49(2):329-40. PubMed ID: 19925018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.
    Santillana E; Beceiro A; Bou G; Romero A
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5354-9. PubMed ID: 17374723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and Functional Characterization of OXA-48: Insight into Mechanism and Structural Basis of Substrate Recognition and Specificity.
    Chiou J; Cheng Q; Shum PT; Wong MH; Chan EW; Chen S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.
    Werner JP; Mitchell JM; Taracila MA; Bonomo RA; Powers RA
    Protein Sci; 2017 Mar; 26(3):515-526. PubMed ID: 27997706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic and structural requirements for carbapenemase activity in GES-type β-lactamases.
    Stewart NK; Smith CA; Frase H; Black DJ; Vakulenko SB
    Biochemistry; 2015 Jan; 54(2):588-97. PubMed ID: 25485972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products.
    Hinchliffe P; Calvopiña K; Rabe P; Mojica MF; Schofield CJ; Dmitrienko GI; Bonomo RA; Vila AJ; Spencer J
    J Biol Chem; 2023 May; 299(5):104606. PubMed ID: 36924941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class D β-lactamases: a reappraisal after five decades.
    Leonard DA; Bonomo RA; Powers RA
    Acc Chem Res; 2013 Nov; 46(11):2407-15. PubMed ID: 23902256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases.
    Chudyk EI; Beer M; Limb MAL; Jones CA; Spencer J; van der Kamp MW; Mulholland AJ
    ACS Infect Dis; 2022 Aug; 8(8):1521-1532. PubMed ID: 35877936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases.
    Docquier JD; Calderone V; De Luca F; Benvenuti M; Giuliani F; Bellucci L; Tafi A; Nordmann P; Botta M; Rossolini GM; Mangani S
    Chem Biol; 2009 May; 16(5):540-7. PubMed ID: 19477418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Multidrug-Resistant
    Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems.
    Stojanoski V; Hu L; Sankaran B; Wang F; Tao P; Prasad BVV; Palzkill T
    ACS Infect Dis; 2021 Feb; 7(2):445-460. PubMed ID: 33492952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.
    Schroder EC; Klamer ZL; Saral A; Sugg KA; June CM; Wymore T; Szarecka A; Leonard DA
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6155-64. PubMed ID: 27480863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.
    Kasap M; Torol S; Kolayli F; Dundar D; Vahaboglu H
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):990-6. PubMed ID: 22845331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
    Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
    ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.
    Endimiani A; Doi Y; Bethel CR; Taracila M; Adams-Haduch JM; O'Keefe A; Hujer AM; Paterson DL; Skalweit MJ; Page MG; Drawz SM; Bonomo RA
    Biochemistry; 2010 Feb; 49(5):1014-23. PubMed ID: 19938877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.